The last few years have brought about many changes in our approach to the management of on acute myocardial mhrclion. A number of investigators have begun to claim that certain of their research studies almost mandate a near total reorientation of our thinking as to what constitutes the best therapy for on acute myocardial ischemic event: the trend is rather unmistakably in favor of very aggressive management for patients with a fresh heart attack. Nevertbelesr jeopardized by only one of its three coronary vessels, IS sometimes seriously injured. A went study (61, for instance, has shown quite persuasively that the myocardial area at ri\k in patients with an acute myocardial infarction is governed by variables that can caor: similar sites of occlosion within a sinale coronary artery to result in a wide range random&d to medical or sorgi&+l therapy. Despite these of damage. Fonhermore. this stuby maintains that "many convincing data, however. it is not fully (or perhaps not even readdy avadable indexes"-including the coronary artery pardotty) warrooted to soggest that these findings alway?
anatomy--cannot be used to accurately predict the size of accurately represent the prognosis of patients who, in addirhe risk area. Tbece investigators appropriately urge o de-sented by the prcscnce of infarct zone thallium redistribution in patients with an acute myocardial infarction and sing:e vessel coronary disease. Because las already stated) other studies 141 using thallium investigations seem to be muck less optimistic, one must strongly endorse the authors' plea for future randomized trials targeted to assess the diagnostic and therapeutic options in patients with an acute ischemic event and sinele vessel disease. Such a broader effort is needed not only be&se of the continuing divergent therapeutic recommendations (often including a substantial proponion of Patients with single VCSSCI disease) (7). but also because certain problems in the present study may hinder interpretation of its conctusions. It is troublesome lhat no attcmot was made in this study to standardize the medical therapy. For exam-"le. it is a relatively common practice today to treat patients with Q wave myocardial infarciion with a beta-adrenergic blocker. those with a non-Q wave infarction with diltiazem or those with unstable angina wi!h aspirin because a number of studies show that such interventions can improve prognosis. The results of this reoort could therefore be a bit skewed because the commo~iy considered "best therapy"
might not have been uniformly followed and different medics approaches may have kah a substantial impact on the eventual clinical outcome. Furthermore, a number of hypotheses evoked in this study are related to myocardial oxygen supply and demand. [t would have been extremely useful to see if the analysis of left ventricular wali mass would further classify its subjects according to future coronary events. This is even more important now that we are beginning to recognize that increases in left ventricular mass (in patients who presumably have no coronary artery disease) predispose to significant subsequent cardiovascular morbid events (8). Unfortunately, contrast left vetttrictdograpky was not performed in this study, and these rather important ventricular wall mass date are therefore apparently unavailable.
Despite these difficulties, however. the work by Wilson et rd. (I) represents a much needed first step toward a better understanding of which diagnostic evaluations give the best overview of problems confronting a patient with an acme myocardial infarction and Crgle vessel coronary artery disease. It should form P solid basis for the next crucial step: how to use these and subsequent diagnostic data to decide which of these patients should be treated aggressively with angioplasty or surgery and which can be safely managed with a conservative approach.
